Kinapse CEO stepping down
pharmafile | September 24, 2010 | News story | | Kinapse
24 September, 2010
London, UK
The Board of Directors of Kinapse Ltd. today announced that Co-founder Shalabh Kumar has stepped down as Chief Executive Officer, effective immediately. He will continue as a Shareholder and as a Non-executive Director on the Board of Kinapse Ltd.
Nick Edwards, Chairman of Kinapse Ltd., said, “I would like to thank Shalabh for his contributions as a Co-founder, Chief Operating Officer and then Chief Executive of Kinapse. He has played a significant role in building Kinapse as a business and as an organisation in the last five years. We look forward to his continued support to the growth of the business as a member of the Board and wish him well.”
Shalabh Kumar said, “It has been an exciting and demanding five years of building Kinapse and I am thankful to all the people, clients, employees and others, who have supported us in the journey. I believe Kinapse has a great future in its chosen lines of business but have had differences with the Board over the strategic focus of the business and have hence agreed to step away from an executive role in the company.”
Kinapse Ltd.
About Kinapse
Kinapse provides consulting and outsourcing services to the global life sciences industries.
Our clients include many of the world’s leading pharmaceutical, biotechnology, medical device and specialty pharmaceutical companies, government organisations and life sciences service providers.
Kinapse specialises in addressing the challenges of life sciences. We understand the complex issues faced throughout the life sciences value chain and offer innovative insights, advice and service delivery to our clients.
Contact:
info@kinapse.com, +44 (0)208 946 7600
Related Content
Service Insight: Discovery metrics – creating the right balance
SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in …
The Project Management Office – Accelerating Project Management Maturity
Success in the life sciences industry depends on allocation of scarce resource to the right …
Offshore outsourcing in Regulatory Affairs and Pharmacovigilance
Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore …
